CC

Chundi Chandrahasa

Active Director Designated Partner DIN 08433285
DIN 08433285 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Chundi Chandrahasa

Data last updated:

Chundi Chandrahasa is a Designated Partner at Ehc Pharmacy Llp (since 2026) and Director at Ehc Services Private Limited (since 2026).

DIN 08433285
Primary Designation Designated Partner
First Appointment 03 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ehc Pharmacy Llp ADA-3442
Designated Partner21 Jul 20262026Active
Ehc Services Private Limited U87300TS2026PTC210648
Director03 Feb 20262026Active

Board colleagues of Chundi Chandrahasa

Directorship timeline

Open interactive timeline →
Ehc Services Private Limited
Ehc Pharmacy Llp
Premium access

Shareholding and investment profile for Chundi Chandrahasa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chundi Chandrahasa

Chundi Chandrahasa currently holds 2 directorships: Ehc Pharmacy Llp (Designated Partner, since 21 Jul 2026); Ehc Services Private Limited (Director, since 03 Feb 2026).

Chundi Chandrahasa was first appointed on 03 Feb 2026 as Director at Ehc Services Private Limited.

The current boards of Chundi Chandrahasa's companies include Shashidhar Komaravolu (Ehc Pharmacy Llp), Vijay Kumar Paidipalli (Ehc Pharmacy Llp), Bala Tripura Sundari Alamalakala (Ehc Services Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available